Hot Features
NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology t... NeuroScientific Biopharmaceuticals Limited engages in the research and development of biomedical products targeting neurodegenerative conditions. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. NeuroScientific Biopharmaceuticals Limited was incorporated in 2002 and is based in Perth, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.013 | -13 | 0.1 | 0.105 | 0.087 | 434735 | 0.09184408 | DE |
| 4 | -0.018 | -17.1428571429 | 0.105 | 0.13 | 0.087 | 478463 | 0.0973287 | DE |
| 12 | -0.011 | -11.2244897959 | 0.098 | 0.13 | 0.069 | 387961 | 0.1030501 | DE |
| 26 | -0.018 | -17.1428571429 | 0.105 | 0.18 | 0.069 | 375172 | 0.12253092 | DE |
| 52 | 0.035 | 67.3076923077 | 0.052 | 0.26 | 0.051 | 410326 | 0.14541552 | DE |
| 156 | -0.006 | -6.45161290323 | 0.093 | 0.26 | 0.033 | 335764 | 0.09606712 | DE |
| 260 | -0.223 | -71.935483871 | 0.31 | 0.54 | 0.033 | 280733 | 0.14152692 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.